Colorado pauses use of Johnson & Johnson vaccine following reports of rare blood clots [Video]

DENVER — Following guidance from the CDC and the FDA, the Colorado Department of Public Health and Environment announced Tuesday it is asking providers to temporarily stop the use of the single-dose Johnson & Johnson COVID-19 vaccine.

The CDC and the FDA in a joint statement recommended the pause Tuesday morning following six cases of a “rare and severe type of blood clot” in women who had received the J&J vaccine.

“All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination,” the statement read.

The CDPHE emphasized that these cases are extremely rare. As of April 12, more than 6.8 million doses of the J&J vaccine have been administered in the United States. In Colorado, over 120,000 people have received the J&J vaccine, according to the latest data. For comparison, nearly 3.2 million doses of the Pfizer and Moderna vaccines …